ScinoPharm Taiwan (TWSE: 1789) today announced a landmark achievement in the global pharmaceutical landscape, securing U.S. Food ...
Zurich, Zurich - January 06, 2026 - PRESSADVANTAGE - Perfect Esthetics, a Zurich-based aesthetic medicine clinic, ...
Migraines affect millions in the UK, yet are often misunderstood and underestimated. From throbbing pain and nausea to ...
CorMedix Therapeutics (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening ...
Uncover how an AI system developed at KAIST optimizes injection moulding processes and transfers critical knowledge to ...
In April 2025, CMG Pharmaceutical, a subsidiary of CHA Biotech, secured FDA approval for Mezofy (formerly Depipzo), an oral ...
The FDA approved Scinopharm's glatiramer acetate injection, a generic version of Copaxone, to treat multiple sclerosis.
News we're reading • Loaded Gun, Drugs Found With Driver In Union County: Police — Cranford residents are being told that a ...
Novo Nordisk is my top opportunity for 2026, driven by multiple catalysts and a compelling valuation. The Wegovy pill's FDA ...
Explore the transformative potential of bispecific antibodies in multiple myeloma, offering hope for improved patient ...
Longer-term results from the BENEFIT trial show sustained minimal residual disease negativity in newly diagnosed, ...
Record-high EXPAREL sales driven by volume growth of 7 percent, marking strongest fourth quarter performance in three ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback